These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 26376140

  • 21. Systemic amyloidosis with Crohn's disease treated with infliximab.
    Park YK, Han DS, Eun CS.
    Inflamm Bowel Dis; 2008 Mar; 14(3):431-2. PubMed ID: 17932971
    [No Abstract] [Full Text] [Related]

  • 22. Amyloid proteins, precursors, mediator, and enhancer.
    Cohen AS, Shirahama T, Sipe JD, Skinner M.
    Lab Invest; 1983 Jan; 48(1):1-4. PubMed ID: 6401828
    [No Abstract] [Full Text] [Related]

  • 23. Diagnostic pitfalls and treatment in a young man with systemic amyloidosis.
    Persey MR, Baguley E, Shields ML, Hawkins PN.
    Lancet; 1996 Aug 17; 348(9025):484-5. PubMed ID: 8709820
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Long-term efficacy of infliximab treatment for AA-amyloidosis secondary to chronic inflammatory arthritis.
    Keersmaekers T, Claes K, Kuypers DR, de Vlam K, Verschueren P, Westhovens R.
    Ann Rheum Dis; 2009 May 17; 68(5):759-61. PubMed ID: 19366896
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis.
    Okuda Y, Takasugi K.
    Arthritis Rheum; 2006 Sep 17; 54(9):2997-3000. PubMed ID: 16947531
    [Abstract] [Full Text] [Related]

  • 30. Experiences on the use of biological drugs in psoriatic arthritis-associated amyloidosis.
    Immonen K, Kauppi M, Hakala M.
    Scand J Rheumatol; 2011 May 17; 40(3):236-8. PubMed ID: 21231814
    [No Abstract] [Full Text] [Related]

  • 31. Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.
    Hawkins PN, Wootton R, Pepys MB.
    J Clin Invest; 1990 Dec 17; 86(6):1862-9. PubMed ID: 2254450
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
    Jager PL, Hazenberg BP, Franssen EJ, Limburg PC, van Rijswijk MH, Piers DA.
    J Nucl Med; 1998 Apr 17; 39(4):699-706. PubMed ID: 9544684
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.